ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th
1. ANI Pharmaceuticals CEO Nikhil Lalwani will host meetings at a key forum. 2. The forum focuses on therapeutics in immunology and metabolism. 3. ANI emphasizes growth in its Rare Disease, Generics, and Brands businesses. 4. Innovative therapeutics development highlights ANI's commitment to patient care.